Behcet’s Disease: Causes, Symptoms, and Treatment of Behcet’s Syndrome
Behcet’s disease is a rare and complex autoimmune condition that can affect various body systems. This article provides essential information about its possible causes, clinical symptoms, and current treatment options. Whether you have been recently diagnosed or wish to better understand this condition, you will learn more about how Behcet’s disease can be effectively recognized and managed.
What is Behcet’s Disease?
Behcet’s disease is a chronic inflammatory condition that affects blood vessels throughout the body. This complex pathology is classified as a systemic vasculitis, with the potential to affect both small and large vessels. Although the exact cause remains unknown, it is considered an autoimmune disease in which your immune system attacks your own healthy tissues.
The main characteristics of Behcet’s disease include recurrent ulcers in the mouth and genital areas, eye inflammation (uveitis), skin lesions, joint involvement, and inflammation of blood vessels (vasculitis). These symptoms can vary significantly from person to person and may appear in episodes (flares), alternating with periods of remission.
In the context of managing Behcet’s disease, the supplement Curcuma ECO Forte can represent a complementary support option. Due to its curcumin content, recognized for its anti-inflammatory effects, this supplement could contribute to reducing the systemic inflammation associated with the condition. Research suggests that curcumin can reduce the production of pro-inflammatory cytokines and positively influence the activity of immune cells involved in the inflammatory process. However, it is essential to emphasize that this supplement does not replace the treatment prescribed by a doctor but can only be used as additional support.
[cta_produs style=”style_1″ product=”140091″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/04/boala-Behcet-curcuma.jpg”]
Causes and Risk Factors of Behcet’s Disease
Although the exact cause of Behcet’s disease remains unknown, recent research has highlighted a complex interplay between genetic, environmental, and immunological factors. Understanding these factors can help you better manage the disease and make informed lifestyle decisions.
Genetic predisposition plays an important role in the onset of Behcet’s disease. The HLA-B51 gene is the strongest genetic association, being present in about 50-70% of patients with this condition. Other involved genes, such as IL23R, IL10, STAT4, and ERAP1, play roles in regulating the immune response. It is essential to know that these genes do not automatically determine the onset of the disease but only indicate an increased predisposition.
Environmental factors can act as triggers for Behcet’s disease in genetically predisposed individuals. Infections with pathogens, such as Streptococcus or herpes simplex virus, can activate an abnormal immune response. Stress and minor skin or mucosal trauma can also trigger symptoms or worsen the course of the disease.
Symptoms and Clinical Manifestations of Behcet’s Syndrome
Behcet’s syndrome is characterized by a wide range of clinical manifestations that can vary significantly from one patient to another. Understanding these symptoms can help you recognize the signs of the disease and seek medical help promptly.
Oral and genital ulcers are often the first and most common symptoms of Behcet’s disease. Oral ulcers tend to be more painful, more numerous, and more persistent than common canker sores. They can appear in clusters and affect not only the tongue and cheeks but also the gums and pharynx. Genital ulcers, although similar to oral ones, tend to leave scars.
Ocular involvement in Behcet’s disease is one of the most severe complications, potentially leading to vision loss if not treated promptly. Ocular manifestations tend to be bilateral, recurrent, and progressive. In addition to uveitis and retinal vasculitis, you may develop hypopyon (accumulation of inflammatory cells in the anterior chamber of the eye) or neuroretinitis.
Diagnosing Behcet’s Disease
Diagnosing Behcet’s disease can be challenging due to the diversity and variability of symptoms. Knowing the steps involved in the diagnostic process gives you the opportunity to be actively involved in your own medical care.
To facilitate the correct identification of the disease, the international medical community uses the International Criteria for Behçet’s Disease (ICBD), recognized for their improved accuracy. These criteria take into account the presence of specific manifestations, such as recurrent oral ulcers, genital lesions, eye inflammation, skin lesions, neurological and vascular symptoms, along with the pathergy test. A cumulative score of at least 4 points suggests a probable diagnosis of Behcet’s disease.
In addition to standard blood tests, new investigation techniques can provide valuable information. Magnetic resonance angiography (MRA) offers a detailed visualization of blood vessels, being useful in detecting vasculitis and aneurysms. Positron emission tomography (PET) can highlight areas of active inflammation throughout the body.
Treatment Options for Behcet’s Disease
Treating Behcet’s disease can be quite complicated, as each person may have different symptoms. Therefore, it is important that it be tailored to each individual case and coordinated by a team of specialists.
The main goal of treatment is to reduce inflammation, relieve symptoms, and prevent long-term complications. For milder forms of the disease, common anti-inflammatory medications may be sufficient. However, in more severe cases or when symptoms do not respond to standard treatments, doctors may recommend more modern therapies.
Some of these treatments include medications that target specific parts of the immune system, such as IL-17 inhibitors (e.g., secukinumab), used mainly for skin lesions and joint pain, or JAK inhibitors (such as tofacitinib), which can act quickly on general symptoms. Additionally, recent research shows that stem cell treatments can help regulate immune responses in severe forms of the disease.
Treatment is chosen based on the severity of symptoms and which parts of the body are affected. For example, for severe eye inflammation (uveitis), combinations of immunosuppressive drugs and special biological therapies are often used. If blood clots (thrombosis) occur, anticoagulants may be administered along with anti-inflammatory medications, but under close medical supervision, due to the risk of bleeding.
Living with Behcet’s Disease: Management and Adaptation Strategies
Living with Behcet’s disease presents unique challenges that require a holistic and personalized approach. Beyond medical treatment, there are numerous strategies you can adopt to improve your quality of life and more effectively manage this chronic condition.
To cope with the daily manifestations of the disease, you can adopt some simple but effective practices. Using cold compresses can help reduce inflammation in the case of oral and genital ulcers. Maintaining rigorous oral hygiene is essential for preventing secondary infections. Wearing sunglasses and avoiding prolonged exposure to bright light can help protect your eyes.
Lifestyle changes can have a significant impact on the course of the disease. Adopting an anti-inflammatory diet, rich in omega-3 fatty acids and antioxidants, can help reduce systemic inflammation. Regular moderate-intensity exercise, adapted to your health status, can improve overall well-being and reduce stress.
Research and Future Prospects in Behcet’s Disease
Recent research in the field of Behcet’s disease brings hope for improving diagnosis, treatment, and the quality of life for patients. These advances can help you look to the future with optimism and stay informed about potential new treatment options.
New discoveries in the pathogenesis of the disease have shed light on the molecular mechanisms involved. The role of the gut microbiome in modulating the immune response has become a major area of interest. Studies have identified new intracellular signaling pathways involved in inflammation, offering potential targets for future therapies. Epigenetic research has highlighted changes in gene expression, opening new perspectives for understanding and treating the disease.
Innovations in diagnosis promise more accurate and earlier identification of Behcet’s disease. The development of specific biomarkers for disease activity could revolutionize how the condition is monitored and treated. The use of artificial intelligence in analyzing clinical and imaging data offers the possibility of faster and more precise diagnoses.
Behcet’s disease remains a complex and challenging condition, but advances in its understanding, diagnosis, and treatment offer real hope for improving the quality of life for patients. From new discoveries in pathogenesis to innovative therapies and personalized treatment approaches, every step forward in research brings tangible benefits to those living with this disease.
References
1. Hatemi, G., et al. (2018). 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Annals of the Rheumatic Diseases, 77(6), 808-818.
2. Leccese, P., & Alpsoy, E. (2019). Behçet’s Disease: An Overview of Etiopathogenesis. Frontiers in Immunology, 10, 1067.
3. Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A Review of Its Effects on Human Health. Foods, 6(10), 92.
4. Davatchi, F., et al. (2017). Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Review of Clinical Immunology, 13(1), 57-65.
Photo source: Shutterstock.com